Evidence map›Paper›PMID 24793365›Full record

Trial reportDrug and alcohol dependence2014

Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment.

Sarah W Yip, Elise E DeVito, Hedy Kober, Patrick D Worhunsky, Kathleen M Carroll, Marc N Potenza

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Cannabis Addiction and the Brain: a Review.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sarah W YipDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Elise E DeVitoDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Hedy KoberDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Patrick D WorhunskyDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Kathleen M CarrollDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Marc N PotenzaDivision of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; Department of Neurobiology, Yale University School of Medicine, New Haven, CT, USA; Yale Child Study Center, Yale University School of Medicine, New Haven, CT, USA. Electronic address: marc.potenza@yale.edu.
Yale University · US

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
SUBSTANCE ABUSEK12DA000167 · NIDA · YALE UNIVERSITY · PI STEPHANIE S O'MALLEY, Marc N Potenza · 1991 to 2026
$17.7M
Research Training Fellowship in Substance use and Addiction (RTFSA)T32DA007238 · NIDA · YALE UNIVERSITY · PI BRIAN D. KILUK, ISMENE L. PETRAKIS · 1988 to 2026
$5.7M
Yale BIRCWH Scholar Program on Women's Health and Addictive BehaviorsK12DA031050 · NIDA · YALE UNIVERSITY · PI MAZURE, CAROLYN M. · 2010 to 2014
$2.5M
Neural mechanisms of CBT in cocaine dependence (Gender Differences Supplement)R01DA035058 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M., POTENZA, MARC N · 2013 to 2016
$2.3M
fMRI of CBT and CM for Cocaine DependenceR01DA020908 · NIDA · YALE UNIVERSITY · PI POTENZA, MARC N · 2005 to 2009
$1.7M
Translational Neuroscience Research in Alcoholism (TNRA-TP)T32AA015496 · NIAAA · YALE UNIVERSITY · PI PETRAKIS, ISMENE L. · 2005 to 2014
$1.6M
NCATS NIH HHS UL1 TR000142NIAAA NIH HHS T32 AA015496NIDA NIH HHS K12 DA000167NIDA NIH HHS K12DA00167NIDA NIH HHS K12 DA031050NIDA NIH HHS K12DA031050NIDA NIH HHS P50 DA009241NIDA NIH HHS P50DA09241NIDA NIH HHS R01 DA020908NIDA NIH HHS R01 DA035058NIDA NIH HHS R01DA035058NIDA NIH HHS T32 DA007238NIDA NIH HHS T32 DA007238-23
6 · The paper itself

Abstract

backgroundCannabis is widely abused, and efficacies of therapeutics for cannabis dependence remain suboptimal. Magnetic resonance imaging (MRI) may aid in the identification of biological markers for successful treatment outcomes (i.e., abstinence).

methodsTwenty men with cannabis dependence and twenty non-substance-using healthy comparison (HC) men underwent MRI scanning. Cannabis-dependent individuals then participated in a 12-week randomized clinical trial of behavioral treatments (contingency management (CM), cognitive behavioral therapy (CBT) or both). Pretreatment functional and structural data were compared between the cannabis-dependent and HC participants. In addition, individuals with cannabis dependence were subdivided based on the successful achievement of 21 days of consecutive abstinence during treatment to assess whether abstinent versus non-abstinent cannabis-dependent participants displayed different pretreatment functional and structural characteristics when compared to HC participants.

resultsIn comparison to HC participants, cannabis-dependent participants demonstrated greater ventral striatal activation during the receipt of losing outcomes and smaller putamenal volumes. Cannabis-dependent participants who did not subsequently achieve 21 days of consecutive abstinence had increased activity within the striatum during the receipt of losing outcomes, relative to HC participants. Cannabis-dependent participants who did not achieve 21 days of abstinence had decreased bilateral putamen volumes prior to treatment, relative to HC participants.

conclusionsIndividual differences in pretreatment striatal function and structure may relate to individual differences in treatment responses for cannabis dependence. While mechanisms underlying these associations require further exploration, the striatum might mediate treatment responses via its role in associative reward-learning (e.g., through skills training in CBT or reinforcement of abstinence in CM).

Indexed as

Cognitive Behavioral TherapyRewardAdultBrainFemaleHumansMagnetic Resonance ImagingMaleMarijuana AbusePsychomotor PerformanceReaction TimeSubstance Withdrawal SyndromeYoung AdultCannabis dependenceCognitive behavioral therapyContingency managementfMRIFSL-FIRSTReward processing

Identifiers

PMID24793365
PMCPMC4057888
OpenAlexW2023028229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.